The Latest in Multiple Sclerosis Hub

Some MS treatments may heighten COVID risk

April 28, 2021

Multiple Sclerosis

Evobrutinib may lower nerve damage biomarker levels

April 23, 2021

Multiple Sclerosis

Common MS treatment wears off more quickly in Black patients

April 20, 2021

Multiple Sclerosis

Can supplementary estrogen relieve MS symptoms in menopausal women?

March 17, 2021

Multiple Sclerosis

Neurologic drug prices jump 50% in five years

March 16, 2021

Multiple Sclerosis

Sun exposure linked to reduced pediatric MS risk

March 12, 2021

Multiple Sclerosis

Erythropoietin falls short of neuroprotection in optic neuritis

March 12, 2021

Multiple Sclerosis

Disease progression and therapy response vary in MS by ethnicity

March 10, 2021

Multiple Sclerosis

Newly approved drugs offer new hope in NMOSD

March 10, 2021

Multiple Sclerosis

Infections – especially urinary and kidney – are higher in MS

March 9, 2021

Multiple Sclerosis

Anti-CD20s linked to higher COVID-19 severity in MS

March 5, 2021

Multiple Sclerosis

Certain DMTs in MS may attenuate COVID-19 vaccines

March 5, 2021

Multiple Sclerosis

Natalizumab postinfusion reactions rare; is monitoring necessary?

March 4, 2021

Multiple Sclerosis

NfL levels linked to worse disability in real-world MS

March 3, 2021

Multiple Sclerosis

Vitamin D deficiency linked to early cognitive impairment in MS

March 3, 2021

Multiple Sclerosis